Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy should not be discontinued in low- and middle-income countries
dc.contributor.author | Ballot, Daynia E. | |
dc.contributor.author | Ramdin, Tanusha D. | |
dc.contributor.author | Bandini, Rossella M. | |
dc.contributor.author | Nakwa, Firdose | |
dc.contributor.author | Velaphi, Sithembiso | |
dc.contributor.author | Coetzee, Melantha | |
dc.contributor.author | Masemola, Khomotso | |
dc.contributor.author | Kali, Gugulabatembunamahlubi J.D. | |
dc.contributor.author | Horn, Alan R. | |
dc.contributor.author | Pillay, Shakti | |
dc.contributor.author | Van Rensburg, Jeanne | |
dc.contributor.author | Pepper, Michael Sean | |
dc.date.accessioned | 2022-10-18T04:41:31Z | |
dc.date.available | 2022-10-18T04:41:31Z | |
dc.date.issued | 2021-12 | |
dc.description.abstract | Perinatal asphyxia is a major cause of death and disability in children. Therapeutic hypothermia (TH) has become a standard of care for newborn infants who have sustained hypoxic ischaemic encephalopathy (HIE) due to perinatal asphyxia. There is compelling evidence to support this approach. A Cochrane systematic review of 11 prospective randomised controlled trials including 1 505 newborns showed that TH started within 6 hours of birth in infants with HIE significantly decreased mortality and neurodevelopmental disability in survivors. | en_US |
dc.description.department | Immunology | en_US |
dc.description.department | Paediatrics and Child Health | en_US |
dc.description.librarian | dm2022 | en_US |
dc.description.uri | http://www.samj.org.za | en_US |
dc.identifier.citation | Ballot, D.E., Ramdin, T.D., Bandini, R.M. et al. Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy should not be discontinued in low- and middle-income countries. South African Medical Journal, vol. 111, no. 12, pp. 1168-1169, dec. 2021. doi:10.7196/SAMJ.2021.v111i12.16180. | en_US |
dc.identifier.issn | 2078- 5135 (online) | |
dc.identifier.issn | 0256-9574 (print) | |
dc.identifier.other | 10.7196/SAMJ.2021.v111i12.16180 | |
dc.identifier.uri | https://repository.up.ac.za/handle/2263/87763 | |
dc.language.iso | en | en_US |
dc.publisher | Health and Medical Publishing Group | en_US |
dc.rights | This open-access article is distributed under Creative Commons licence CC-BY-NC 4.0. | en_US |
dc.subject | Therapeutic hypothermia | en_US |
dc.subject | Hypothermia | en_US |
dc.subject | Neonatal | en_US |
dc.subject | Low- and middle-income countries (LMICs) | en_US |
dc.subject | Perinatal asphyxia | en_US |
dc.subject | Children | en_US |
dc.subject | Hypoxic ischaemic encephalopathy (HIE) | en_US |
dc.title | Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy should not be discontinued in low- and middle-income countries | en_US |
dc.type | Article | en_US |